Vanguard Portfolio Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
BBA
Vanguard Portfolio Management's MDGL Position: Q3 2026 in Review
Vanguard Portfolio Management reduced its Madrigal Pharmaceuticals (MDGL) stake by 2.6% in Q3 2026, selling an estimated $10.9M and leaving 761,024 shares worth $384M. The position accounts for 0.02% of the portfolio, ranked #799.
Vanguard Portfolio Management first reported a position in MDGL in Q1 2026 and has held it in 3 quarters since. The position peaked at $440M in Q1 2026. 429 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- Vanguard Portfolio Management held 761,024 shares of Madrigal Pharmaceuticals worth $384M as of Q3 2026.
- Vanguard Portfolio Management sold 20,707 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $10.9M.
- Madrigal Pharmaceuticals made up 0.02% of Vanguard Portfolio Management's portfolio in Q3 2026, its #799 holding.
- Vanguard Portfolio Management first reported a position in Madrigal Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- Vanguard Portfolio Management's Madrigal Pharmaceuticals position peaked at $440M in Q1 2026.
- 429 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.